Cargando…
The current status of anti-GPCR drugs against different cancers
G protein coupled receptors (GPCRs) have emerged as the most potential target for a number of drug discovery programs ranging from control of blood pressure, diabetes, cure for genetic diseases to treatment of cancer. A panel of different ligands including hormones, peptides, ions and small molecule...
Autores principales: | Usman, Sana, Khawer, Maria, Rafique, Shazia, Naz, Zara, Saleem, Komal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775845/ https://www.ncbi.nlm.nih.gov/pubmed/33425448 http://dx.doi.org/10.1016/j.jpha.2020.01.001 |
Ejemplares similares
-
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
por: Laeremans, Toon, et al.
Publicado: (2022) -
Probing GPCR Dimerization Using Peptides
por: Farooq, Zara, et al.
Publicado: (2022) -
Tools for GPCR drug discovery
por: Zhang, Ru, et al.
Publicado: (2012) -
Pharmacogenomics of GPCR Drug Targets
por: Hauser, Alexander S., et al.
Publicado: (2018) -
Multiplexed selectivity screening of anti-GPCR antibodies
por: Dahl, Leo, et al.
Publicado: (2023)